Silicon Laboratories (SLAB) FY2015 results: revenue $645 million, up 3.9% on the year
Silicon Laboratories Inc. (SLAB) reported revenue of $645 million for fiscal 2015, the year ended 2 January 2016, up 3.9% on the year before. Net income was $30 million, down 22.2%, and diluted earnings per share $0.69. The figures are the company's own, from the 10-K it filed with the SEC on 5 February 2016.
Revenue
$645 million
+3.9% on the year
FY2008FY2015
Operating margin
5.0%
8.3% a year earlier
FY2008FY2015
Net income
$30 million
-22.2% on the year
FY2008FY2015
Diluted EPS
$0.69
-20.7% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
645
621
580
+3.9%
Cost of revenue
264
242
227
+9.0%
Gross profit
381
379
353
+0.6%
Gross margin
59.1%
61.0%
60.8%
Research and development
188
173
158
+8.7%
Selling, general and administrative
160
154
131
+4.1%
Operating income
32.2
51.4
64.3
-37.3%
Operating margin
5.0%
8.3%
11.1%
Interest expense
2.8
3.2
3.3
-10.3%
Pre-tax income
30.3
49.0
62.0
-38.3%
Income tax
0.7
11.0
12.2
-93.9%
Effective tax rate
2.2%
22.5%
19.7%
Net income
29.6
38.0
49.8
-22.2%
Net margin
4.6%
6.1%
8.6%
Diluted EPS
$0.69
$0.87
$1.14
-20.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
105
137
120
-23.3%
Capital expenditure
11.3
11.2
10.5
+0.4%
Free cash flow
94.2
126
110
-25.4%
Free cash flow margin
14.6%
20.3%
18.9%
Cash from investing
-49.3
n/a
n/a
Cash from financing
-83.8
n/a
n/a
Depreciation and amortisation
39.0
30.5
28.1
+28.1%
Share-based compensation
42.8
39.1
30.8
+9.5%
Buybacks
71.4
71.7
26.0
-0.3%
Diluted shares, weighted
43m
44m
44m
-1.9%
Shares outstanding at period end
42m
42m
43m
-1.2%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
761
758
739
+0.4%
Debt
77.5
87.5
95.0
-11.4%
Other liabilities
173
197
158
-12.3%
Total liabilities and equity
1,011
1,043
991
-3.0%
Fixed assets
131
133
132
-1.3%
Goodwill
273
229
229
+19.2%
Intangible assets
121
115
132
+5.5%
Investments
136
201
190
-32.3%
Cash and equivalents
114
142
95.8
-19.5%
Receivables
73.6
70.4
72.1
+4.6%
Inventory
53.9
52.6
45.3
+2.4%
Other assets
109
100
94.9
+8.3%
Total assets
1,011
1,043
991
-3.0%
10-K for the year ended 2 January 2016, filed 5 February 2016: the filing.